BIM
OCRX

BlackRock Investment Management’s Ocera Therapeutics, Inc. OCRX Stock Holding History

BlackRock Investment Management’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$6K Hold
2,764
– – ﹤0.01% 3753
2016
Q3 		$7K Buy
2,764
+378
+16% +$944 ﹤0.01% 3729
2016
Q2 		$5K Hold
2,386
– – ﹤0.01% 3871
2016
Q1 		$7K Hold
2,386
– – ﹤0.01% 3758
2015
Q4 		$7K Buy
2,386
+264
+12% +$902 ﹤0.01% 3807
2015
Q3 		$7K Hold
2,122
– – ﹤0.01% 3847
2015
Q2 		$8K Hold
2,122
– – ﹤0.01% 3828
2015
Q1 		$10K Hold
2,122
– – ﹤0.01% 3671
2014
Q4 		$14K Hold
2,122
– – ﹤0.01% 3567
2014
Q3 		$10K Buy
2,122
+460
+28% +$2.65K ﹤0.01% 3686
2014
Q2 		$13K Buy
+1,662
New +$13.2K ﹤0.01% 3552

Other funds holding OCRX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

BlackRock Investment Management's OCRX Position: Q4 2016 in Review

BlackRock Investment Management held its Ocera Therapeutics, Inc. (OCRX) position steady in Q4 2016 at 2,764 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #3753.

BlackRock Investment Management first reported a position in OCRX in Q2 2014 and has held it in 11 quarters since. The position peaked at $14K in Q4 2014. 36 funds tracked by Wall St. Rank hold OCRX as of Q4 2016.

  • BlackRock Investment Management held 2,764 shares of Ocera Therapeutics, Inc. worth $6K as of Q4 2016.
  • BlackRock Investment Management left its Ocera Therapeutics, Inc. share count unchanged in Q4 2016.
  • Ocera Therapeutics, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3753 holding.
  • BlackRock Investment Management first reported a position in Ocera Therapeutics, Inc. in Q2 2014 and has held it in 11 quarters since.
  • BlackRock Investment Management's Ocera Therapeutics, Inc. position peaked at $14K in Q4 2014.
  • 36 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.